MX Bio

About:

MX Bio is a MedTech startup that has developed a suite of three complimentary solutions to help prevent and cure periodontal disease.

Website: http://mx-bio.com/

Top Investors: POSCO CAPITAL, A Ventures, HB Investment, KB Securities, Seoul Business Agency(SBA)

Description:

MX Bio is a MedTech startup that is addressing periodontal disease, also known as gum disease, an ailment that affects approximately 11.2% of the world’s population. MX Bio has developed a suite of three complimentary solutions to help prevent periodontal disease, and to cure it once it becomes a problem: 1. A biodegradable chip that is inserted between the teeth and releases medication in a controlled manner during one week of effective, efficient treatment, killing the germs that cause periodontal disease. 2. A compound antibiotic ointment that has completed successful preclinical trials. 3. An ointment and membrane type periodontal regeneration inducer. MX Bio's solutions have been developed with ultimate efficacy in mind. The company can deliver them for around 30% of the current market price, across the product range.

Total Funding Amount:

5.6B KRW

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2018-06-01

Contact Email:

ceo(AT)mx-bio.com

Founders:

Jae Hyun Lee

Number of Employees:

1-10

Last Funding Date:

2021-06-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai